Commentary: Microvesicles: A target for personalized medicine following coronary artery bypass grafting

J Thorac Cardiovasc Surg. 2022 Feb;163(2):700-701. doi: 10.1016/j.jtcvs.2020.11.021. Epub 2020 Nov 19.

Authors

Nicolas H Pope¹, Arman Kilic²

Affiliations

¹ Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, SC.
² Division of Cardiac Surgery, The University of Pittsburgh Medical Center, Pittsburgh, Pa. Electronic address: kilica2@upmc.edu.

PMID: 33323198
DOI: 10.1016/j.jtcvs.2020.11.021

No abstract available

Publication types

Editorial
Comment

MeSH terms

Coronary Artery Bypass*
Humans
Precision Medicine*